Skip to main content

Antithrombotics in heart failure: background to the WARCEF study

Pullicino, Patrick, Thompson, John L. P. (2003) Antithrombotics in heart failure: background to the WARCEF study. Seminars in Cerebrovascular Disease and Stroke, 3 . pp. 4-7. ISSN 1528-9931. (doi:10.1053/scds.2003.00019) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:12241)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
https://doi.org/doi:10.1053/scds.2003.00019

Abstract

Three controlled clinical studies in the early 1950s reported that warfarin reduced death and

of stroke by warfarin in "cardiomyopathy" and many clinicians use warfarin for this purpose. The

reduction difficult and a prospective study costly. As for atrial fibrillation, there may be subgroups

be defined. Cognitive impairment is increasingly recognized as a complication of heart failure, and

Ejection Fraction) study reduces its sample size by combining death and stroke as the primary

endpoint and by including patients with prior stroke.

Item Type: Article
DOI/Identification number: 10.1053/scds.2003.00019
Additional information: NOT IN FILE
Subjects: R Medicine > R Medicine (General)
Divisions: Faculties > Sciences > Kent Institute of Medicine and Health Sciences (KIMHS)
Depositing User: M.P. Stone
Date Deposited: 10 Sep 2008 13:44 UTC
Last Modified: 28 May 2019 13:48 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/12241 (The current URI for this page, for reference purposes)
  • Depositors only (login required):